90 related articles for article (PubMed ID: 25110352)
41. Trifunctional somatostatin-based derivatives designed for targeted radiotherapy using auger electron emitters.
Ginj M; Hinni K; Tschumi S; Schulz S; Maecke HR
J Nucl Med; 2005 Dec; 46(12):2097-103. PubMed ID: 16330576
[TBL] [Abstract][Full Text] [Related]
42. ¹¹¹In-Bn-DTPA-nimotuzumab with/without modification with nuclear translocation sequence (NLS) peptides: an Auger electron-emitting radioimmunotherapeutic agent for EGFR-positive and trastuzumab (Herceptin)-resistant breast cancer.
Fasih A; Fonge H; Cai Z; Leyton JV; Tikhomirov I; Done SJ; Reilly RM
Breast Cancer Res Treat; 2012 Aug; 135(1):189-200. PubMed ID: 22736376
[TBL] [Abstract][Full Text] [Related]
43. Hyperbranched double hydrophilic block copolymer micelles of poly(ethylene oxide) and polyglycerol for pH-responsive drug delivery.
Lee S; Saito K; Lee HR; Lee MJ; Shibasaki Y; Oishi Y; Kim BS
Biomacromolecules; 2012 Apr; 13(4):1190-6. PubMed ID: 22414172
[TBL] [Abstract][Full Text] [Related]
44. [In vitro stimulation by ellipticine derivatives of DNA cleavage induced by DNA topoisomerase II: a structure-activity relationship].
Fossé P; Charra M; Paoletti C; Saucier JM; René B
Bull Cancer; 1994 Mar; 81(3):194-202. PubMed ID: 7894127
[TBL] [Abstract][Full Text] [Related]
45. Thermosensitive poly(organophosphazene)-paclitaxel conjugate gels for antitumor applications.
Chun C; Lee SM; Kim SY; Yang HK; Song SC
Biomaterials; 2009 Apr; 30(12):2349-60. PubMed ID: 19178941
[TBL] [Abstract][Full Text] [Related]
46. Hyaluronate tethered, "smart" multiwalled carbon nanotubes for tumor-targeted delivery of doxorubicin.
Datir SR; Das M; Singh RP; Jain S
Bioconjug Chem; 2012 Nov; 23(11):2201-13. PubMed ID: 23039830
[TBL] [Abstract][Full Text] [Related]
47. Biodegradable ZnO@polymer core-shell nanocarriers: pH-triggered release of doxorubicin in vitro.
Zhang ZY; Xu YD; Ma YY; Qiu LL; Wang Y; Kong JL; Xiong HM
Angew Chem Int Ed Engl; 2013 Apr; 52(15):4127-31. PubMed ID: 23463695
[No Abstract] [Full Text] [Related]
48. Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy.
Wu XL; Kim JH; Koo H; Bae SM; Shin H; Kim MS; Lee BH; Park RW; Kim IS; Choi K; Kwon IC; Kim K; Lee DS
Bioconjug Chem; 2010 Feb; 21(2):208-13. PubMed ID: 20073455
[TBL] [Abstract][Full Text] [Related]
49. Comb-like amphiphilic copolymers bearing acetal-functionalized backbones with the ability of acid-triggered hydrophobic-to-hydrophilic transition as effective nanocarriers for intracellular release of curcumin.
Zhao J; Wang H; Liu J; Deng L; Liu J; Dong A; Zhang J
Biomacromolecules; 2013 Nov; 14(11):3973-84. PubMed ID: 24107101
[TBL] [Abstract][Full Text] [Related]
50. Differential effects of ellipticine and aza-analogue derivatives on cell cycle progression and survival of BALB/c 3T3 cells released from serum starvation or thymidine double block.
Vilarem MJ; Charcosset JY; Primaux F; Gras MP; Calvo F; Larsen CJ
Cancer Res; 1985 Aug; 45(8):3906-11. PubMed ID: 4016757
[TBL] [Abstract][Full Text] [Related]
51. Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance.
Ge Z; Liu S
Chem Soc Rev; 2013 Sep; 42(17):7289-325. PubMed ID: 23549663
[TBL] [Abstract][Full Text] [Related]
52. Antitumor activity of imidazothioxanthones in murine and human tumor models in vitro and in vivo.
Varvaresou A; Iakovou K; Gikas E; Fichtner I; Fiebig HH; Kelland LR; Double JA; Bibby MC; Hendriks HR
Anticancer Res; 2004; 24(2B):907-19. PubMed ID: 15161044
[TBL] [Abstract][Full Text] [Related]
53. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
[TBL] [Abstract][Full Text] [Related]
54. A novel anti-VEGF targeting and MRI-visible smart drug delivery system for specific diagnosis and therapy of liver cancer.
Huang H; Li Y; Li C; Wang Y; Sun Y; Wang J
Macromol Biosci; 2013 Oct; 13(10):1358-68. PubMed ID: 23852809
[TBL] [Abstract][Full Text] [Related]
55. Iodine-Rich Polymersomes Enable Versatile SPECT/CT Imaging and Potent Radioisotope Therapy for Tumor in Vivo.
Cao J; Wei Y; Zhang Y; Wang G; Ji X; Zhong Z
ACS Appl Mater Interfaces; 2019 May; 11(21):18953-18959. PubMed ID: 31062589
[TBL] [Abstract][Full Text] [Related]
56. Ellipticine-loaded apoferritin nanocarrier retains DNA adduct-based cytochrome P450-facilitated toxicity in neuroblastoma cells.
Indra R; Černá T; Heger Z; Hraběta J; Wilhelm M; Dostálová S; Lengálová A; Martínková M; Adam V; Eckschlager T; Schmeiser HH; Arlt VM; Stiborová M
Toxicology; 2019 May; 419():40-54. PubMed ID: 30914192
[TBL] [Abstract][Full Text] [Related]
57. Auger electrons and DNA double-strand breaks studied by using iodine-containing chemicals.
Higashi Y; Ma Y; Matsumoto K; Shiro A; Saitoh H; Kawachi T; Tamanoi F
Enzymes; 2022; 51():101-115. PubMed ID: 36336404
[TBL] [Abstract][Full Text] [Related]
58. In Vitro Evaluation of No-Carrier-Added Radiolabeled Cisplatin ([
Obata H; Tsuji AB; Sudo H; Sugyo A; Minegishi K; Nagatsu K; Ogawa M; Zhang MR
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33924843
[TBL] [Abstract][Full Text] [Related]
59. Nuclear quantum effects in a HIV/cancer inhibitor: The case of ellipticine.
Sappati S; Hassanali A; Gebauer R; Ghosh P
J Chem Phys; 2016 Nov; 145(20):205102. PubMed ID: 27908111
[TBL] [Abstract][Full Text] [Related]
60. Redox parameters associated to cytotoxic and antitumor activities in the series of antitumor drugs ellipticines and derivatives.
Auclair C
Adv Exp Med Biol; 1990; 264():317-22. PubMed ID: 2244509
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]